Charles River Laboratories | CRL - Cost Of Sales

Stock Price
189.24
Daily Change
5.54 3.02%
Monthly
-12.70%
Yearly
15.54%
Q1 Forecast
204.00

Charles River Laboratories reported $693.46M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Agilent USD 871M 28M Sep/2025
Align Technology USD 363.97M 7.48M Dec/2025
Bio-Rad Laboratories USD 306.3M 31.5M Jun/2025
Bruker USD 481.1M 41.6M Sep/2025
Cardinal Health USD 63.36B 1.57B Dec/2025
Charles River Laboratories USD 693.46M 20.52M Sep/2025
Cigna USD 63.37B 1.93B Sep/2025
CVS Health USD 89.07B 3.74B Sep/2025
Danaher USD 2.87B 342M Dec/2025
Dentsply International USD 463M 17M Sep/2025
Elevance Health USD 38.07B 75M Dec/2025
Galapagos EUR 84.73M 80.02M Sep/2025
Hologic USD 463.7M 5.1M Dec/2025
Humana USD 26.54B 1.15B Mar/2025
Illumina USD 400M 49M Dec/2025
Incyte USD 99M 20.23M Sep/2025
IQVIA Holdings USD 3.24B 518M Dec/2025
Laboratory Of America USD 2.54B 11M Sep/2025
Lonza CHF 2.28B 189M Jun/2025
McKesson USD 102.47B 2.86B Dec/2025
Merck EUR 2.1B 123M Sep/2025
Mettler Toledo International USD 473.97M 33.71M Dec/2025
Novartis USD 3.54B 217M Sep/2025
Pfizer USD 6.29B 2.12B Dec/2025
Quest Diagnostics USD 1.91B 49M Sep/2025
Revvity USD 324.34M 3.38M Sep/2025
Thermo Fisher Scientific USD 7.58B 674M Dec/2025
United Therapeutics USD 100.9M 74.3M Sep/2025
UnitedHealth USD 92.52B 920M Sep/2025
Waters USD 327.81M 5.5M Sep/2025
West Pharmaceutical Services USD 510.3M 17.7M Sep/2025